0001193125-24-150357.txt : 20240530 0001193125-24-150357.hdr.sgml : 20240530 20240530162530 ACCESSION NUMBER: 0001193125-24-150357 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 13 CONFORMED PERIOD OF REPORT: 20240529 ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers FILED AS OF DATE: 20240530 DATE AS OF CHANGE: 20240530 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Minerva Neurosciences, Inc. CENTRAL INDEX KEY: 0001598646 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 260784194 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-36517 FILM NUMBER: 241005689 BUSINESS ADDRESS: STREET 1: 1601 TRAPELO ROAD STREET 2: SUITE 286 CITY: WALTHAM STATE: MA ZIP: 02451 BUSINESS PHONE: 617-600-7373 MAIL ADDRESS: STREET 1: 1601 TRAPELO ROAD STREET 2: SUITE 286 CITY: WALTHAM STATE: MA ZIP: 02451 8-K 1 d798417d8k.htm 8-K 8-K
NASDAQ false 0001598646 0001598646 2024-05-29 2024-05-29

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): May 29, 2024

 

 

Minerva Neurosciences, Inc.

(Exact name of registrant as specified in its charter)

 

 

 

Delaware   000-36517   26-0784194
(State or other jurisdiction
of incorporation)
  (Commission
File Number)
  (IRS Employer
ID Number)

 

1500 District Avenue, Burlington, MA 01803
(Address of principal executive offices) (Zip Code)

(617) 600-7373

(Registrant’s telephone number, including area code)

Not Applicable

(Former Name or Former Address, if Changed Since Last Report)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

 

Trading
Symbol(s)

 

Name of each exchange
on which registered

Common Stock, $0.0001 par value per share   NERV   The Nasdaq Capital Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 


Item 5.02

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On May 29, 2024, Jeryl Hilleman notified the Board of Directors (the “Board”) of Minerva Neurosciences, Inc. (the “Company”) of her intention to resign as a member of the Board, effective August 6, 2024, including from her role as Chair of the Audit Committee of the Board. Ms. Hilleman is resigning to focus on other opportunities and her decision did not involve any disagreement with the Company, its management or the Board.

Following Ms. Hilleman’s notification of resignation, the Board appointed (i) Jan van Heek, who currently serves as a member of the Audit Committee, as the new Chair of the Audit Committee and (ii) Dr. David Kupfer, a current director on the Board, as a new member of the Audit Committee, each effective upon the effective time of Ms. Hilleman’s resignation on August 6, 2024.


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

    MINERVA NEUROSCIENCES, INC.
Dated: May 30, 2024     By:  

/s/ Geoffrey Race

    Name:   Geoffrey Race
    Title:   President
EX-101.SCH 2 nerv-20240529.xsd XBRL TAXONOMY EXTENSION SCHEMA 100000 - Document - Document and Entity Information link:calculationLink link:presentationLink link:definitionLink EX-101.LAB 3 nerv-20240529_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Cover [Abstract] Cover [Abstract] Security Exchange Name Security Exchange Name Amendment Flag Amendment Flag Entity Central Index Key Entity Central Index Key Document Type Document Type Document Period End Date Document Period End Date Entity Registrant Name Entity Registrant Name Entity Incorporation State Country Code Entity Incorporation State Country Code Entity File Number Entity File Number Entity Tax Identification Number Entity Tax Identification Number Entity Address, Address Line One Entity Address, Address Line One Entity Address, City or Town Entity Address, City or Town Entity Address, State or Province Entity Address, State or Province Entity Address, Postal Zip Code Entity Address, Postal Zip Code City Area Code City Area Code Local Phone Number Local Phone Number Written Communications Written Communications Soliciting Material Soliciting Material Pre Commencement Tender Offer Pre Commencement Tender Offer Pre Commencement Issuer Tender Offer Pre Commencement Issuer Tender Offer Security 12b Title Security 12b Title Trading Symbol Trading Symbol Entity Emerging Growth Company Entity Emerging Growth Company EX-101.PRE 4 nerv-20240529_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE XML 6 R1.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Document and Entity Information
May 29, 2024
Cover [Abstract]  
Security Exchange Name NASDAQ
Amendment Flag false
Entity Central Index Key 0001598646
Document Type 8-K
Document Period End Date May 29, 2024
Entity Registrant Name Minerva Neurosciences, Inc.
Entity Incorporation State Country Code DE
Entity File Number 000-36517
Entity Tax Identification Number 26-0784194
Entity Address, Address Line One 1500 District Avenue
Entity Address, City or Town Burlington
Entity Address, State or Province MA
Entity Address, Postal Zip Code 01803
City Area Code (617)
Local Phone Number 600-7373
Written Communications false
Soliciting Material false
Pre Commencement Tender Offer false
Pre Commencement Issuer Tender Offer false
Security 12b Title Common Stock, $0.0001 par value per share
Trading Symbol NERV
Entity Emerging Growth Company false
EXCEL 7 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx M4$L#!!0 ( "Z#OE@'04UB@0 +$ 0 9&]C4')O<',O87!P+GAM M;$V./0L",1!$_\IQO;=!P4)B0-!2L+(/>QLOD&1#LD)^OCG!CVX>;QA&WPIG M*N*I#BV&5(_C(I(/ !47BK9.7:=N')=HI6-Y #OGDK7A.YNJQ<&4GPZ4A!0W_J=0U[R;UEA_6\#MI7E!+ P04 M " N@[Y8TQTL7N\ K @ $0 &1O8U!R;W!S+V-O&ULS9)1 M2\,P$,>_BN2]O31U"J'+BV-/"H(#Q;>0W+9@TX3DI-VWMZU;A^@'\#%W__SN M=W"-B=*$A,\I1$SD,-\,ONVR-''-CD11 F1S1*]S.2:ZL;D/R6L:G^D 49L/ M?4 0G-^!1])6DX8)6,2%R%1CC30)-85TQENSX.-G:F>8-8 M>NPH0U56P-0T M,9Z&MH$K8((1)I^_"V@7XES]$SMW@)V30W9+JN_[LJ_GW+A#!6]/CR_SNH7K M,NG.X/@K.TFGB&MVF?Q:/VQV6Z8$%[<%7Q4UWPDNQ4J*^_?)]8??5=@'Z_;N M'QM?!%4#O^Y"?0%02P,$% @ +H.^6)E&UL[5I;<]HX%'[OK]!X9_9M"\8V@;:T$W-I=MNTF83M M3A^%$5B-;'EDD81_OTV23;J;/ 0LZ?O.14?GZ#AY\^XN8NB&B)3R M> +]O6N[!3+ MUES@6QHO(];JM-O=5H1I;*$81V1@?5XL:$#05%%:;U\@M.4?,_@5RU2-9:,! M$U=!)KF(M/+Y;,7\VMX^9<_I.ATR@6XP&U@@?\YOI^1.6HCA5,+$P&IG/U9K MQ]'22(""R7V4!;I)]J/3%0@R#3LZG5C.=GSVQ.V?C,K:=#1M&N#C\7@XMLO2 MBW A(5M>5 TR M6'!VULS2 Y9>*?IUE!K9';O=05SP6.XYB1'^QL4$UFG2&98T1G*=D 4. #?$ MT4Q0?*]!MHK@PI+27)#6SRFU4!H(FLB!]4>"(<7K;YH] M5Z%82=J$^!!&&N*<<^9ST6S[!Z5&T?95O-RCEU@5 9<8WS2J-2S%UGB5P/&M MG#P=$Q+-E L&08:7)"82J3E^34@3_BNEVOZKR2.FJW"$2M"/F(9 M-AIRM1:!MG&IA&!:$L;1>$[2M!'\6:PUDSY@R.S-D77.UI$.$9)>-T(^8LZ+ MD!&_'H8X2IKMHG%8!/V>7L-)P>B"RV;]N'Z&U3-L+([W1]072N0/)J<_Z3(T M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+ M.7\N?<^E[[GT/:'2MSAD6R4)RU3393>* M$IY"&V[I4_5*E=?EK[DHN#Q;Y.FOH70^+,_Y/%_GM,T+,T.WF)&Y M"M-2D&_#^>G%>!KB.=D$N7V85VWGV-'1^^?!4;"C[SR6'<>(\J(A[J&&F,_# M0X=Y>U^89Y7&4#04;6RL)"Q&MV"XU_$L%.!D8"V@!X.O40+R4E5@,5O& RN0 MHGQ,C$7H<.>77%_CT9+CVZ9EM6ZO*7<9;2)2.<)IF!-GJ\K>9;'!51W/55OR ML+YJ/;053L_^6:W(GPP13A8+$DACE!>F2J+S&5.^YRM)Q%4XOT4SMA*7&+SC MYL=Q3E.X$G:V#P(RN;LYJ7IE,6>F\M\M# DL6XA9$N)-7>W5YYNTB42%(JP# 4A M%W+C[^^3:G>,U_HL@6V$5#)DU1?*0XG!/3-R0]A4)?.NVB8+A=OB5,V[&KXF M8$O#>FZ=+2?_VU[4/;07/4;SHYG@'K.' MYA,L0Z1^P7V*BH 1JV*^NJ]/^26<.[1[\8$@F_S6VZ3VW> ,?-2K6J5D*Q$_ M2P=\'Y(&8XQ;]#1?CQ1BK::QK<;:,0QY@%CS#*%F.-^'19H:,]6+K#F-"F]! MU4#E/]O4#6CV#30,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04 M" N@[Y8FD_3L%4$ "8$ & 'AL+W=O=-@X/SYV3[^'[O#G51O>L.Y(?LX2O3(V1B3WKJN#C8\9OI&ICR! M)RNI8F:@J=:N3A5G81X41Z[O>5TW9B)QQL/\WDR-AS(SD4CX3!&=Q3%3ASL> MR=W(H<[[C5>QWAA[PQT/4[;FGOGMVU M_L97P7?ZY)K8KBRE?+.-IW#D>):(1SPP5H+!SY9/>119)>#X]RCJE-^T@:?7 M[^J/>>>A,TNF^51&WT1H-B.G[Y"0KU@6F5>Y^YT?.]2Q>H&,=/Z7[(IWVYY# M@DP;&1^#@2 62?'+]L>!. WPSP3XQP _YRX^E%/>,\/&0R5W1-FW0Y%W- MHP%.)'96YD;!4P%Q9GPO@PP&V1"6A.0A,<(\* M0?^,X#,[$']P17S/;W\?[0):R>>7?'XNUSHC-Y5;KLC?DZ4V"F;PGSJ@0J%= MKV#3^E:G+. C!_)6<[7ESOBG'VC7^Q7A:Y5\+4Q]/.=!INR@/>R##4O6G+RP MF-=1XCHOD_G]Y \$J%T"M5&A"Q01V$$6+[FJ]5%+0R>HKZ]#OA) S!I2%7CA?D,[Q'OB2UL]D@23N> M1^YM)HO D,F6)QEF;;0R?8J[]4?6J6U)119R5U\R<;F[3,&MM?E8;[^GJRH MQ2W\(UVQ,@!OIN16P$JL1<0UGR<86E44Z$55H42;26V@.OPETK,KMD'1HWVO MA;%5E8'BWIY/X@2VMN=1<(&?N[3W"X92U0>*V_IG&<"HS#8R00T$%^F"@?1: M/71PJKI <4/_!IL+Q*]?W<<.>*9X/CZUUQ18#=F*P>?VR6M7/7X->(UEE_C[NU/\C M>](Z [)&0%RV$?!DDX\;=;F+IOZ2+(2):I=?@XCM8;X/D,';%?G1N[$;1Y(R M1;8LRCA)H:MZPQ2*7)4 '_?LA6*A3;WY(5[*VL1K$'AY>/V*D51V[U]D]P\Q M5VM+]!LHF(V=\)0EM?OM!L&S\^J>G#/MF?V9V2]J$O$5"'DW/;!J51R#BX:1 M:7[T7$H#!]G\&PO9KEMW MDOSAR+DCO9*ZW="C<\W[)&D/1ZY8^\XT7'ND,E8QYU5;)VUC.2M;<%(R6=[< M9(EB0M-BK3MUIUQ+#J;3;D-O:%*L*Z//EI0&@U_*%">/3&[HEDFQMV)8RY20 MIV!>@N%@I+'$>2I\0Q=@:9\"O @:L!SC**&-!6,2,H3O_;C\&3!IK5>%E#/! M)0V&8MTPY[C5=UX9%@_&%Q 9Y=VI\0QKRTZ+Y2T].PP_/LG>V)+;.'36-/+T08I:*Q[V_LL)BS6;_,C16/'DL\&D'+R!6TH>N77B<&GY85FS MX[V;IJFO<,[+?Y#SGZUSS36W3%Z2]J/_-U?Y+8R3\?1<'-&K SI;"5R$&_H5 M[E=YYD#VG9!.Z%$[BK+D^L4Y]>$=V_L+_"J^7U_RBG72[69P0\_R%UZ*3N7S MJGNHR[CJ+'^&^VB1S;>PSR5TR7M>;D?5UOM!)%[P6<<'')XC=\,31S"?@,41 MP+ \& /,)WAA>?ZG_:S0_00,X[:*(BO49X7Z!*\8LAT^6)ZX3^Z?^$[S/$VS M#*OH=AMEL,7JEF7P%X^&<0,/+ ]D>ENM\6[C$_+Z'& ]?6U"L)WBDXCM%*\U M(/&Z@4>>Q[N-Y0$/K O8[$#^>!Z8J;A/FD)7,6[8"<:1/,<0F,7XC&894IT, M/O'^8* \^>Q\ETWLJ.?]74_P$4$L# M!!0 ( "Z#OEB7BKL

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end XML 8 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 9 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 11 FilingSummary.xml IDEA: XBRL DOCUMENT 3.24.1.1.u2 html 1 22 1 false 0 0 false 0 false false R1.htm 100000 - Document - Document and Entity Information Sheet http://minervaneurosciences.com//20240529/taxonomy/role/DocumentDocumentAndEntityInformation Document and Entity Information Cover 1 false false All Reports Book All Reports [ix-0514-Hidden-Fact-Eligible-For-Transform] WARN: 1 fact(s) appearing in ix:hidden were eligible for transformation: dei:SecurityExchangeName - d798417d8k.htm 7 d798417d8k.htm nerv-20240529.xsd nerv-20240529_lab.xml nerv-20240529_pre.xml http://xbrl.sec.gov/dei/2023 true false JSON 14 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "d798417d8k.htm": { "nsprefix": "nerv", "nsuri": "http://minervaneurosciences.com/20240529", "dts": { "inline": { "local": [ "d798417d8k.htm" ] }, "schema": { "local": [ "nerv-20240529.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd", "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd", "https://xbrl.sec.gov/naics/2023/naics-2023.xsd" ] }, "labelLink": { "local": [ "nerv-20240529_lab.xml" ] }, "presentationLink": { "local": [ "nerv-20240529_pre.xml" ] } }, "keyStandard": 22, "keyCustom": 0, "axisStandard": 0, "axisCustom": 0, "memberStandard": 0, "memberCustom": 0, "hidden": { "total": 3, "http://xbrl.sec.gov/dei/2023": 3 }, "contextCount": 1, "entityCount": 1, "segmentCount": 0, "elementCount": 23, "unitCount": 0, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2023": 22 }, "report": { "R1": { "role": "http://minervaneurosciences.com//20240529/taxonomy/role/DocumentDocumentAndEntityInformation", "longName": "100000 - Document - Document and Entity Information", "shortName": "Document and Entity Information", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "duration_2024-05-29_to_2024-05-29", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "p", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d798417d8k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "duration_2024-05-29_to_2024-05-29", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "p", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d798417d8k.htm", "first": true, "unique": true } } }, "tag": { "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentFlag", "presentation": [ "http://minervaneurosciences.com//20240529/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Amendment Flag", "terseLabel": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CityAreaCode", "presentation": [ "http://minervaneurosciences.com//20240529/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "City Area Code", "terseLabel": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "label": "Cover [Abstract]", "terseLabel": "Cover [Abstract]", "documentation": "Cover page." } } }, "auth_ref": [] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodEndDate", "presentation": [ "http://minervaneurosciences.com//20240529/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Period End Date", "terseLabel": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentType", "presentation": [ "http://minervaneurosciences.com//20240529/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Type", "terseLabel": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine1", "presentation": [ "http://minervaneurosciences.com//20240529/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line One", "terseLabel": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCityOrTown", "presentation": [ "http://minervaneurosciences.com//20240529/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, City or Town", "terseLabel": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://minervaneurosciences.com//20240529/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, Postal Zip Code", "terseLabel": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://minervaneurosciences.com//20240529/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, State or Province", "terseLabel": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCentralIndexKey", "presentation": [ "http://minervaneurosciences.com//20240529/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r1" ] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://minervaneurosciences.com//20240529/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r1" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFileNumber", "presentation": [ "http://minervaneurosciences.com//20240529/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity File Number", "terseLabel": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://minervaneurosciences.com//20240529/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Incorporation State Country Code", "terseLabel": "Entity Incorporation State Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityRegistrantName", "presentation": [ "http://minervaneurosciences.com//20240529/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r1" ] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://minervaneurosciences.com//20240529/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Tax Identification Number", "terseLabel": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r1" ] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "LocalPhoneNumber", "presentation": [ "http://minervaneurosciences.com//20240529/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Local Phone Number", "terseLabel": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "dei_PreCommencementIssuerTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementIssuerTenderOffer", "presentation": [ "http://minervaneurosciences.com//20240529/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Pre Commencement Issuer Tender Offer", "terseLabel": "Pre Commencement Issuer Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act." } } }, "auth_ref": [ "r3" ] }, "dei_PreCommencementTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementTenderOffer", "presentation": [ "http://minervaneurosciences.com//20240529/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Pre Commencement Tender Offer", "terseLabel": "Pre Commencement Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act." } } }, "auth_ref": [ "r4" ] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12bTitle", "presentation": [ "http://minervaneurosciences.com//20240529/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Security 12b Title", "terseLabel": "Security 12b Title", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r0" ] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityExchangeName", "presentation": [ "http://minervaneurosciences.com//20240529/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Security Exchange Name", "terseLabel": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r2" ] }, "dei_SolicitingMaterial": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SolicitingMaterial", "presentation": [ "http://minervaneurosciences.com//20240529/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Soliciting Material", "terseLabel": "Soliciting Material", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act." } } }, "auth_ref": [ "r5" ] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "TradingSymbol", "presentation": [ "http://minervaneurosciences.com//20240529/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Trading Symbol", "terseLabel": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "dei_WrittenCommunications": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "WrittenCommunications", "presentation": [ "http://minervaneurosciences.com//20240529/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Written Communications", "terseLabel": "Written Communications", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act." } } }, "auth_ref": [ "r6" ] } } } }, "std_ref": { "r0": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r1": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r2": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r3": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "13e", "Subsection": "4c" }, "r4": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14d", "Subsection": "2b" }, "r5": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Section": "14a", "Number": "240", "Subsection": "12" }, "r6": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "425" } } } ZIP 15 0001193125-24-150357-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001193125-24-150357-xbrl.zip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end XML 17 d798417d8k_htm.xml IDEA: XBRL DOCUMENT 0001598646 2024-05-29 2024-05-29 NASDAQ false 0001598646 8-K 2024-05-29 Minerva Neurosciences, Inc. DE 000-36517 26-0784194 1500 District Avenue Burlington MA 01803 (617) 600-7373 false false false false Common Stock, $0.0001 par value per share NERV false